Skip to main content
H

Hemorai

Hemorai develops advanced wearable technology for continuous, real-time monitoring of patient blood loss and vital signs. This medical device technology provides instant alerts to caregivers when critical thresholds are detected. The system offers portable, easy-to-use monitoring designed to improve health outcomes for both patients and healthcare providers.

Austin, United StatesFounded 2019350+ followers
Updated 3 months ago

Funding

$35K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BA
Funding rounds are not available yet.

Founders

Product

Problem

Continuous monitoring of blood loss and vital signs is often limited to clinical settings, hindering proactive health management for patients outside of traditional care environments. This lack of continuous, real-time data can delay critical interventions for conditions involving internal bleeding or significant fluid loss.

Solution

Hemorai offers an AI-powered wearable system designed for continuous, non-invasive blood loss monitoring and vital sign tracking. The system comprises a discreet wearable device that captures physiological data and proprietary algorithms that analyze these signals to quantify blood loss and detect deviations from baseline vital signs. Real-time alerts are transmitted to designated caregivers and healthcare providers via a secure platform when predefined critical thresholds are breached. This enables timely intervention and proactive management of patient health, improving outcomes through accessible, immediate medical insights.

Target Audience

The primary target audience includes healthcare providers, hospital systems, and home healthcare agencies seeking to enhance patient monitoring capabilities for individuals at risk of or recovering from conditions involving significant blood loss.

Features

  • Wearable biosensor device for continuous, non-invasive monitoring of blood loss indicators and core vital signs (e.g., heart rate, respiration rate).
  • AI-driven signal processing algorithms for real-time quantification of blood loss and anomaly detection.
  • Secure, cloud-based data aggregation and analysis platform.
  • Configurable alert system delivering notifications to caregivers and healthcare providers upon detection of critical events.
  • Patient-friendly interface for ease of use and adherence.
  • Data transmission via encrypted communication protocols to ensure data integrity and privacy.
This profile is AI-generated and may contain inaccuracies.